CHO cells for virus-like particle and subunit vaccine manufacturing
ZV Sanchez-Martinez, SP Alpuche-Lazcano, M Stuible… - Vaccine, 2024 - Elsevier
Abstract Chinese Hamster Ovary (CHO) cells, employed primarily for manufacturing
monoclonal antibodies and other recombinant protein (r-protein) therapeutics, are emerging …
monoclonal antibodies and other recombinant protein (r-protein) therapeutics, are emerging …
Increased efficacy of influenza virus vaccine candidate through display of recombinant neuraminidase on virus like particles
L Guzman Ruiz, AM Zollner, I Hoxie, E Arcalis… - Frontiers in …, 2024 - frontiersin.org
Vaccination against influenza virus can reduce the risk of influenza by 40% to 60%, they rely
on the production of neutralizing antibodies specific to influenza hemagglutinin (HA) …
on the production of neutralizing antibodies specific to influenza hemagglutinin (HA) …